BioArctic AB Sustainability Reports
BioArctic AB is a Swedish research-based biopharmaceutical company focused on developing disease-modifying treatments for neurodegenerative disorders, such as Alzheimer's and Parkinson's disease.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300Y0OI2WVUNHLC33
FIGI: BBG00HVQ6XJ1
18 reports from 2017 to 2025
